MarketCap
Facebook
X
Telegram
Ocean Bio-Chem Balance Sheet 2021-2009 | OBCI
Brief overview of Ocean Bio-Chem's assets and capital
The comparison uses five available annual reports from the 2017–2021 interval.
Assets reached $60.3 million, compared with $32 million at the beginning. Growth of +88.4% and CAGR near 17.2% show active expansion.
The growth rates were balanced: assets changed +88.4%, while liabilities changed +81%.
Equity funds 78.7% of assets versus 77.8% initially. This creates a conservative balance sheet structure.
The balance sheet holds more cash than interest-bearing debt; net debt is -$4.8 million, indicating minimal leverage.
The cash reserve occupies 21% of the balance sheet, previously 7.6%. It is one marker of short-term resilience.
Retained earnings are $36.6 million versus $15.2 million initially. The direction shows how results contributed to equity.
Overall assessment
Ocean Bio-Chem's balance sheet looks resilient: assets are supported by substantial equity, while debt does not overwhelm financial flexibility.
Annual Balance Sheet Ocean Bio-Chem
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-4.84 M | -7.31 M | -1.9 M | 3.11 M | 1.66 M | -4.02 M | -2.14 M | -2.37 M | -1.95 M | 23.9 K | 1.75 M | 2.38 M | - |
Long Term Debt |
7.75 M | 3.73 M | 4.14 M | 4.51 M | 4.08 M | 50.4 K | 329 K | 692 K | 1.12 M | 1.53 M | 1.94 M | 2.51 M | - |
Long Term Debt Current |
89.6 K | 86.4 K | 83.3 K | - | - | - | - | - | - | - | 400 K | 490 K | - |
Total Non Current Liabilities |
- | 4.29 M | 4.72 M | 4.79 M | 4.24 M | 264 K | 694 K | 951 K | 1.36 M | 1.76 M | 2.19 M | - | - |
Total Current Liabilities |
4.65 M | 3.7 M | 2.83 M | 3.01 M | 2.86 M | 2.89 M | 2.65 M | 3 M | 2.62 M | 2.82 M | 3.66 M | 3.91 M | - |
Total Liabilities |
12.8 M | 7.99 M | 7.55 M | 7.8 M | 7.09 M | 3.16 M | 3.22 M | 3.95 M | 4.04 M | 4.58 M | 5.85 M | 6.5 M | - |
Retained Earnings |
36.6 M | 29.3 M | 20.4 M | 17.4 M | 15.2 M | 13.1 M | 11.6 M | 11.1 M | 9.48 M | 8.02 M | 6.06 M | 3.67 M | - |
Total Assets |
60.3 M | 47.9 M | 38.3 M | 35.2 M | 32 M | 25.7 M | 23.9 M | 24 M | 22.3 M | 21 M | 19.9 M | 17.7 M | - |
Cash and Cash Equivalents |
12.7 M | 11.1 M | 6.13 M | 1.4 M | 2.42 M | 4.07 M | 2.47 M | 3.06 M | 3.07 M | 1.51 M | 585 K | 615 K | 495 K |
Book Value |
47.4 M | 39.9 M | 30.7 M | 27.4 M | 24.9 M | 22.5 M | 20.6 M | 20 M | 18.3 M | 16.4 M | 14 M | 11.2 M | - |
Total Shareholders Equity |
47.4 M | 39.9 M | 30.7 M | 27.4 M | 24.9 M | 22.5 M | 20.6 M | 20 M | 18.3 M | 16.2 M | 13.8 M | 10.9 M | 9.36 M |
All numbers in USD currency
Quarterly Balance Sheet Ocean Bio-Chem
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | 7.28 M | 7.52 M | 7.75 M | 7.98 M | 3.47 M | 3.61 M | 3.73 M | 3.85 M | 3.98 M | 4.02 M | 4.14 M | 4.2 M | 4.31 M | 4.42 M | 4.51 M | 4.62 M | 3.96 M | 4.02 M | 4.08 M | 4.16 M | 40.9 K | 45.6 K | 50.4 K | 55.2 K | 97.3 K | 214 K | 329 K | 443 K | 556 K | 585 K | 692 K | 799 K | 906 K | 1.01 M | 1.12 M | 1.22 M | 1.33 M | 1.43 M | 1.53 M | 1.63 M | 1.74 M | 1.84 M | 1.94 M | 2.04 M | 2.27 M | - |
Total Liabilities |
- | - | 17.4 M | 13.6 M | 12.8 M | 16.2 M | 10.4 M | 9.67 M | 7.99 M | 11.2 M | 10.6 M | 8.45 M | 7.55 M | 9.05 M | 8.47 M | 8.97 M | 7.8 M | 13 M | 9.5 M | 8 M | 7.09 M | 9.82 M | 3.84 M | 4.5 M | 3.16 M | 5.14 M | 4.07 M | 4.58 M | 3.22 M | 5.42 M | 4.1 M | 4.18 M | 3.95 M | 4.95 M | 3.91 M | 4.45 M | 4.04 M | 5.71 M | 4.55 M | 4.56 M | 4.58 M | 7.32 M | 5.19 M | 6.17 M | 5.85 M | 10.2 M | 7.59 M | 5.85 M |
Retained Earnings |
- | - | 36.8 M | 37.5 M | 36.6 M | 36.2 M | 33.2 M | 30.9 M | 29.3 M | 28.6 M | 24.1 M | 21.1 M | 20.4 M | 19.8 M | 18.7 M | 17.6 M | 17.4 M | 17.5 M | 16.2 M | 15.1 M | 15.2 M | 14.9 M | 14 M | 13.6 M | 13.1 M | 12.7 M | 11.1 M | 10.5 M | 11.6 M | 11.5 M | 11.2 M | 11.1 M | 11.1 M | 10.6 M | 9.68 M | 9.27 M | 9.48 M | 9.16 M | 8.54 M | 8.37 M | 8.02 M | 7.56 M | 6.79 M | 6.42 M | 6.06 M | 5.84 M | 4.7 M | 6.06 M |
Total Assets |
- | - | 65.1 M | 62 M | 60.3 M | 63.1 M | 54.3 M | 51.2 M | 47.9 M | 50.1 M | 45 M | 39.8 M | 38.3 M | 39.1 M | 37.2 M | 36.7 M | 35.2 M | 40.6 M | 35.5 M | 32.9 M | 32 M | 34.4 M | 27.3 M | 27.5 M | 25.7 M | 27.2 M | 24.3 M | 24.2 M | 23.9 M | 26 M | 24.2 M | 24.2 M | 24 M | 24.5 M | 22.8 M | 22.6 M | 22.3 M | 23.7 M | 21.8 M | 21.3 M | 21 M | 23.2 M | 20.3 M | 20.6 M | 19.9 M | 24 M | 20.2 M | 19.9 M |
Cash and Cash Equivalents |
- | - | 7.02 M | 10.2 M | 12.7 M | 10.7 M | 8.3 M | 11.2 M | 11.1 M | 6.58 M | 4.68 M | 6.15 M | 6.13 M | 2.11 M | 1.11 M | 563 K | 1.4 M | 1.84 M | 923 K | 2.29 M | 2.42 M | 1.32 M | 868 K | 3.4 M | 4.07 M | 1.09 M | 1.8 M | 2.44 M | 2.47 M | 933 K | 2.85 M | 2.01 M | 3.06 M | 1.83 M | 2.71 M | 2.83 M | 3.07 M | 679 K | 1.01 M | 534 K | 1.51 M | 775 K | 1.13 M | 685 K | 585 K | 809 K | 539 K | 585 K |
Book Value |
- | - | 47.7 M | 48.4 M | 47.4 M | 46.9 M | 43.9 M | 41.5 M | 39.9 M | 38.9 M | 34.5 M | 31.4 M | 30.7 M | 30.1 M | 28.7 M | 27.7 M | 27.4 M | 27.6 M | 26 M | 24.9 M | 24.9 M | 24.6 M | 23.4 M | 23 M | 22.5 M | 22.1 M | 20.2 M | 19.6 M | 20.6 M | 20.6 M | 20.1 M | 20 M | 20 M | 19.5 M | 18.9 M | 18.1 M | 18.3 M | 18 M | 17.2 M | 16.8 M | 16.4 M | 15.9 M | 15.1 M | 14.4 M | 14 M | 13.8 M | 12.6 M | 14 M |
Total Shareholders Equity |
- | - | 47.7 M | 48.4 M | 47.4 M | 46.9 M | 43.9 M | 41.5 M | 39.9 M | 38.9 M | 34.5 M | 31.4 M | 30.7 M | 30.1 M | 28.7 M | 27.7 M | 27.4 M | 27.6 M | 26 M | 24.9 M | 24.9 M | 24.6 M | 23.4 M | 23 M | 22.5 M | 22.1 M | 20.2 M | 19.6 M | 20.6 M | 20.6 M | 20.1 M | 20 M | 20 M | 19.5 M | 18.6 M | 17.9 M | 18.3 M | 17.7 M | 17 M | 16.5 M | 16.2 M | 15.6 M | 14.8 M | 14.1 M | 13.8 M | 13.5 M | 12.3 M | 13.8 M |
All numbers in USD currency
Balance Sheet is a fundamental financial report of Ocean Bio-Chem, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Conglomerates
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
NN
NNBR
|
$ 3.31 | -0.9 % | $ 164 M |  USA |
 |
Tejon Ranch Co.
TRC
|
$ 16.93 | -0.7 % | $ 455 M | USA |
 |
SGOCO Group, Ltd.
SGOC
|
- | -0.32 % | $ 718 M |  China |
 |
India Globalization Capital
IGC
|
$ 0.25 | -0.2 % | $ 22.2 M | USA |
 |
Alpha Metallurgical Resources
AMR
|
$ 137.16 | -4.62 % | $ 1.78 B | USA |
 |
Steel Partners Holdings L.P.
SPLP
|
- | 0.57 % | $ 756 M | USA |
 |
Cemtrex
CETX
|
$ 2.47 | -1.2 % | $ 327 K | USA |
 |
Compass Diversified
CODI
|
$ 10.08 | 0.3 % | $ 758 M | USA |
 |
Seaboard Corporation
SEB
|
$ 4 413.26 | -2.04 % | $ 4.25 B | USA |
 |
Icahn Enterprises L.P.
IEP
|
$ 7.79 | 1.04 % | $ 5.24 B | USA |
 |
Matthews International Corporation
MATW
|
$ 27.75 | - | $ 863 M | USA |